Healthcare News

Første pasient dosert med ZI-MA4-1 ved The Christie NHS Foundation Trust. ZI-MA4-1 er verdens første MAGE-A4-rettede TCR-NK-terapi som nå testes i pasienter for første gangMed ZIMA-101 testes...

Company announcement No. 32 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 28, 2026) Copenhagen, Denmark, July 13, 2026 – Zealand Pharma A/S ("the Company" or “Zealand...

MARKHAM, Ontario, July 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") is proud to announce it has been named one of Canada's Best Companies by TIME and Statista...

LONDON, July 13, 2026 (GLOBE NEWSWIRE) -- Scottish brewer and the UK’s leading craft beer brand BrewDog, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), today announced that BrewDog...

Expands potential benefit for treating neuropathic pain in cancer patients, particularly those experiencing weight loss due to cancer Findings suggest broader utility in cancer supportive care,...

COPENHAGEN, Denmark, July 13, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that its partner, Eurofarma, has submitted a marketing authorization application to the Brazilian Health Regulatory...

KØBENHAVN, Danmark, 13. juli 2026 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabets partner, Eurofarma, har indsendt en ansøgning om markedsføringstilladelse til den brasilianske...

Omada Health (Nasdaq: OMDA) announced that members of senior management will participate in Canaccord Genuity’s 46th annual Growth Conference.

Oncolytics announced more than 20 patients pre-identified for REO 033 colorectal cancer trial and scheduled Type D meeting with the FDA.

DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter...